APPB Stock Chart & Stats
<$0.01
$0.00(0.00%)
At close: 4:00 PM EDT
<$0.01
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.10 - $0.10
Previous CloseN/A
Volume1.20K
Average Volume (3M)0.00
Market Cap
$2.20K
Enterprise Value$273.68B
Total Cash (Recent Filing)$21.27K
Total Debt (Recent Filing)$914.52K
Price to Earnings (P/E)―
Beta28.26
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.21
Shares Outstanding22,002,590
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)-9.42
Price to Sales (P/S)30.92
P/FCF Ratio-3.66
Enterprise Value/Market Cap124.40M
Enterprise Value/Revenue318.28K
Enterprise Value/Gross Profit518.02K
Enterprise Value/Ebitda-103.22K
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
APPB FAQ
What was Applied BioSciences Corp.’s price range in the past 12 months?
Applied BioSciences Corp. lowest stock price was $0.10 and its highest was $0.10 in the past 12 months.
What is Applied BioSciences Corp.’s market cap?
Applied BioSciences Corp.’s market cap is $2.20K.
When is Applied BioSciences Corp.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Applied BioSciences Corp.’s earnings last quarter?
Applied BioSciences Corp. released its earnings results on Nov 15, 2019. The company reported -$0.058 earnings per share for the quarter.
Is Applied BioSciences Corp. overvalued?
According to Wall Street analysts Applied BioSciences Corp.’s price is currently Overvalued.
Does Applied BioSciences Corp. pay dividends?
Applied BioSciences Corp. does not currently pay dividends.
What is Applied BioSciences Corp.’s EPS estimate?
Applied BioSciences Corp.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Applied BioSciences Corp. have?
Applied BioSciences Corp. has 22,002,590 shares outstanding.
What happened to Applied BioSciences Corp.’s price movement after its last earnings report?
Applied BioSciences Corp. reported an EPS of -$0.058 in its last earnings report. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Applied BioSciences Corp.?
Currently, no hedge funds are holding shares in APPB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Applied BioSciences Corp.
Applied Biosciences Corp. is dedicated to the creation and market launch of synthetic cannabinoid biopharmaceutical treatments. These advanced therapeutics are specifically designed to interact with the body's endocannabinoid system, aiming to address a wide array of diseases across diverse medical specialties. Furthermore, the company offers over-the-counter, THC-free CBD products directly to consumers, which are intended to support general health and well-being. It also provides specialized testing and analytical services to its customers. The firm was founded in 2014 and operates from its base in Beverly Hills, California.
Technical Analysis
―
Scinai Immunotherapeutics
―
Aditxt
―
Bluejay Diagnostics
―
Virax Biolabs Group Ltd. Class A
―